International Conference on Radiotherapy, Radiology, Imaging and Immunotherapy in Cancer (ICRRIIC - 27)

This track focuses on the latest developments in MRI scanning techniques and their applications in cancer diagnosis and treatment. Participants will explore innovations that enhance image quality and diagnostic accuracy.

This session will delve into recent advancements in computed tomography (CT) technology, emphasizing its role in cancer imaging. Discussions will include improvements in scan speed, resolution, and patient safety.

This track will examine the applications of positron emission tomography (PET) in oncology, highlighting its effectiveness in tumor detection and monitoring treatment response. Case studies and clinical trials will be presented to demonstrate its impact.

This session will explore the integration of PET-CT and PET-MRI technologies in cancer imaging, discussing their comparative advantages and clinical implications. Participants will analyze case studies that illustrate the benefits of hybrid imaging.

This track will address the rationale and mechanisms of immunotherapy in cancer treatment, focusing on innovative approaches to enhance immune responses. Experts will discuss the integration of immunotherapy with traditional therapies.

This session will cover the latest advancements in radiotherapy techniques, including precision targeting and dose optimization. The focus will be on improving patient outcomes through technological innovations.

This track will emphasize the critical role of cancer nursing in patient care, focusing on supportive therapies and patient education. Discussions will include strategies for managing treatment side effects and improving quality of life.

This session will explore the immune biological properties of human cancer stem cells and their implications for treatment. Participants will discuss novel strategies for targeting these cells to improve therapeutic outcomes.

This track will investigate the role of androgen manipulation in cancer treatment, particularly in hormone-sensitive cancers. The session will highlight current research and clinical applications.

This session will focus on innovative strategies for T-cell modulation in cancer immunotherapy. Participants will explore the potential of enhancing T-cell responses to improve therapeutic efficacy.

This track will discuss the application of bite antibodies in the treatment of solid tumors, emphasizing their mechanism of action and clinical outcomes. Experts will share insights from recent clinical trials and research findings.